NCT06172322 2024-04-23
A Phase Ib/â…¡ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer
Nanjing Chia-tai Tianqing Pharmaceutical
Phase 1 Unknown
Clinical Trials
5 trialsNCT06047184 2023-09-21
Phase I Study of BEBT-209 in Women With Advanced Breast Cancer
BeBetter Med Inc
Phase 1 Unknown
NCT05504213 2022-08-17
A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT02626507 2022-02-09
Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer
Hoffman Oncology
Phase 1 Unknown
NCT04856371 2021-04-23
Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer
Haihe Biopharma Co., Ltd.
Phase 1 Unknown